海天天線(08227.HK)成功中標"中國電信湖南公司2021年透鏡天綫集中採購項目"
海天天線(08227.HK)公吿,公司新型人工介質透鏡系列天綫産品("該介質透鏡天綫系列")在中國電信集團有限公司"中國電信湖南公司2021年透鏡天綫集中採購項目"成功中標。中標通知書已於2021年6月1日發出,並將會簽訂銷售合同。該合同總金額約為人民幣172萬元(含税),天綫數量為300台。
公司正積極參與各移動通信網絡運營商天綫採購活動,與各移動通信設備商及系統集成商進行溝通並洽談合作,為預期取得銷售合同作出生產準備。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.